EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair

Veronica Marrella iD, Federico Nicchiotti, Barbara Cassani

International Journal of Molecular Sciences · 05.04.2024 · 25 (7) · 4051

DOI: 10.3390/ijms25074051 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.04.2024. Verfasst von Veronica Marrella und 2 weiteren Autor:innen. Beteiligte Einrichtung: UOS Milan Unit, Istituto di Ricerca Genetica e Biomedica (IRGB), CNR, 20138 Milan, Italy. Hauptthemen laut MEDLINE: Respiratory Tract Infections, Bacteriophages, Microbiota. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 265 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Governo Italiano, Italian PRIN.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial and viral respiratory tract infections are the most common infectious diseases, leading to worldwide morbidity and mortality. In the past 10 years, the importance of lung microbiota emerged in the context of pulmonary diseases, although the mechanisms by which it impacts the intestinal environment have not yet been fully identified. On the contrary, gut microbial dysbiosis is associated with disease etiology or/and development in the lung. In this review, we present an overview of the lung microbiome modifications occurring during respiratory infections, namely, reduced community diversity and increased microbial burden, and of the downstream consequences on host–pathogen interaction, inflammatory signals, and cytokines production, in turn affecting the disease progression and outcome. Particularly, we focus on the role of the gut–lung bidirectional communication in shaping inflammation and immunity in this context, resuming both animal and human studies. Moreover, we discuss the challenges and possibilities related to novel microbial-based (probiotics and dietary supplementation) and microbial-targeted therapies (antibacterial monoclonal antibodies and bacteriophages), aimed to remodel the composition of resident microbial communities and restore health. Finally, we propose an outlook of some relevant questions in the field to be answered with future research, which may have translational relevance for the prevention and control of respiratory infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Tract InfectionsBacteriophagesMicrobiotaAnimalsHumansAntibodies, Monoclonal, HumanizedLung

Stichwörter der Autor:innen

bacteriadysbiosisgut–lung axishost–microbe interactionsmicrobial therapiesmicrobiotamucosal immunityvirus

Substanzen

Antibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • UOS Milan Unit, Istituto di Ricerca Genetica e Biomedica (IRGB), CNR, 20138 Milan, Italy.
  • IRCCS Humanitas Research Hospital, 20089 Milan, Italy.
  • Department of Medical Biotechnologies and Translational Medicine, Università degli Studi di Milano, 20089 Milan, Italy.

ORCID-Profile: Veronica Marrella

Förderung

  • Governo Italiano
  • Italian PRIN

Zitieren

APA

Marrella, V., Nicchiotti, F., & Cassani, B. (2024). Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair. International Journal of Molecular Sciences, 25(7), 4051. https://doi.org/10.3390/ijms25074051

Vancouver

Marrella V, Nicchiotti F, Cassani B. Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair. International Journal of Molecular Sciences. 2024;25(7):4051. doi:10.3390/ijms25074051

BibTeX
@article{Marrella2024,
  author = {Marrella, Veronica and Nicchiotti, Federico and Cassani, Barbara},
  title = {Microbiota and Immunity during Respiratory Infections: Lung and Gut Affair},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {7},
  pages = {4051},
  doi = {10.3390/ijms25074051}
}
Kostenlos starten →